Clinical Trial Update: T2000 in Essential Tremor - Open Label Continuation [Phase 2]

View source ↗

Summary

This clinical trial update notes the termination of a Phase 2 open-label continuation study of T2000 for essential tremor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• T2000

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Essential Tremor | Phase 2 | Status: TERMINATED